Clinical investigation of silybum marianum seed extract (silymarin) treatment in type ii diabetic patients
- At: 2005 FIP Congress in Cairo (Egypt)
- Type: Poster
- By: YOUSEF, Wael (Faculty of Medicine, Clinical pharmacology, Shebin El Kom, Menoufiya, Egypt)
- Co-author(s): Hussieni, Fallah (Institute Medic, TEHRAN, Iran)
Introduction: The free radical production and consequently metabolic oxidative stress disorder is hallmark of chronic disease particularly in uncontrolled hyperinsulinemic type II diabetic patients. Inhibition of free radical production, its neutralization or correction of oxidative metabolic abnormality in diabetic patients following antioxidant.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.